Park City-based DW Healthcare Partners, a healthcare-focused private equity firm, has sold its portfolio company Med-Pharmex Holdings Inc. to Dechra Pharmaceuticals, based in England. Med-Pharmex is a Pomona, California-based veterinary pharmaceutical manufacturer.
“It has been a pleasure to work with Med-Pharmex over the years. Med-Pharmex represents DWHP’s first investment in the animal health space, and since then, we have added three additional animal health investments to our portfolio,” said Andrew Carragher co-founder and managing partner of DW Healthcare Partners. “Dechra is the perfect buyer for Med-Pharmex, and we look forward to watching the company continue to grow and scale under Dechra’s ownership.”
“Med-Pharmex has a rich history, built over nearly 40 years, of efficiently developing, manufacturing and distributing animal health products that are valued by our customers. Our recent investments in people, processes, technologies, and facilities have strengthened our quality foundation enabling us to now support significant growth,” said Paul Hays, Med-Pharmex’s CEO. “I am so proud of our people and what they have accomplished in the last few years. Dechra’s investment, capabilities, and vision for the business will build on this foundation and leverage the ability of our people and site to provide even more value to customers and stakeholders alike.”
DW Healthcare Partners manages over $1.3 billion in aggregate capital commitments and invests in leading healthcare companies with proven management teams. The firm provides capital, strategic guidance and acquisition expertise to help mid-stage companies grow and scale.